Exebacase
N/A
Report date: 2024/04/28 11:22:44
Base Information
Drug NameExebacase
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[14]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Rockefeller University
China Registration ClassN/A
Develop Information
Active CompaniesContrafect Corporation
Inactive CompaniesContrafect
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A